Morgan Stanley’s scPharmaceuticals SCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.18M | Buy |
2,147,886
+261,745
|
|
||||
|
2025
Q1 | $4.96M | Sell |
1,886,141
-23,947
|
|
||||
|
2024
Q4 | $6.76M | Buy |
1,910,088
+1,577,434
|
|
||||
|
2024
Q3 | $1.52M | Buy |
332,654
+111,363
|
|
||||
|
2024
Q2 | $963K | Buy |
221,291
+40,571
|
|
||||
|
2024
Q1 | $907K | Sell |
180,720
-216,452
|
|
||||
|
2023
Q4 | $2.49M | Sell |
397,172
-738,407
|
|
||||
|
2023
Q3 | $8.09M | Sell |
1,135,579
-25,786
|
|
||||
|
2023
Q2 | $11.8M | Sell |
1,161,365
-6,196
|
|
||||
|
2023
Q1 | $10.6M | Buy |
1,167,561
+1,018,583
|
|
||||
|
2022
Q4 | $1.07M | Buy |
148,978
+55,689
|
|
||||
|
2022
Q3 | $608K | Sell |
93,289
-2,414
|
|
||||
|
2022
Q2 | $461K | Buy |
95,703
+9,118
|
|
||||
|
2022
Q1 | $492K | Buy |
86,585
+11,750
|
|
||||
|
2021
Q4 | $375K | Buy |
74,835
+4,742
|
|
||||
|
2021
Q3 | $465K | Buy |
70,093
+8,929
|
|
||||
|
2021
Q2 | $374K | Buy |
61,164
+6,875
|
|
||||
|
2021
Q1 | $361K | Buy |
54,289
+16,748
|
|
||||
|
2020
Q4 | $199K | Buy |
37,541
+4,838
|
|
||||
|
2020
Q3 | $244K | Sell |
32,703
-5,606
|
|
||||
|
2020
Q2 | $282K | Sell |
38,309
-2,193
|
|
||||
|
2020
Q1 | $300K | Sell |
40,502
-4,371
|
|
||||
|
2019
Q4 | $254K | Sell |
44,873
-5,051
|
|
||||
|
2019
Q3 | $293K | Buy |
49,924
+36,291
|
|
||||
|
2019
Q2 | $43K | Buy |
13,633
+3,306
|
|
||||
|
2019
Q1 | $31K | Sell |
10,327
-12,172
|
|
||||
|
2018
Q4 | $84K | Sell |
22,499
-1,108
|
|
||||
|
2018
Q3 | $138K | Sell |
23,607
-52,361
|
|
||||
|
2018
Q2 | $430K | Buy |
75,968
+52,708
|
|
||||
|
2018
Q1 | $288K | Buy |
23,260
+18,195
|
|
||||
|
2017
Q4 | $61K | Buy |
+5,065
|
|